Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Individual Radiosensitivity During Radiotherapy for Breast Cancer Patients, the Role of Genetic and Inflammatory Markers

NCT05566613 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT05566613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05566613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Individual Radiosensitivity During Radiotherapy for Breast Cancer Patients, the Role of Genetic and Inflammatory Markers
Lead sponsor
Karolinska University Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 9, 2022
Completion date
December 31, 2024
Enrollment
550 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, radiation tolerance